Skip to main content

Table 5 Clinical-pathological prognostic features of disease

From: Detection methods predict differences in biology and survival in breast cancer patients

 

False Negative mammograms (n = 20) vs. Incident (n = 65)

P value

OR

Mean age

60.8 + 1.1 vs. 59.7 + 0.6

N.S.

1.04 (0.93-1.15)

Mean size (cm)

1.17 + 0.16 vs. 1.27 + 0.09

N.S.

0.79 (0.34-1.86)

Lymph node positive

6.3% vs. 21.5%

N.S.

0.24 (0.02-2.00)

Poorly differentiated tumors

50% vs. 40%

N.S.

1.50 (0.50-4.49)

ER positive

95% vs. 89%

N.S.

1.59 (0.17-14.4)

PR positive

85.7% vs. 78.2%

N.S.

1.67 (0.32-8.52)

In situ carcinomas

6.3% vs. 11%

N.S.

0.55 (0.06-4.84)

Apoptosis

42.9% vs. 66.7%

N.S.

0.37 (0.06-2.15)

Bcl-2

84.6% vs. 81.3%

N.S.

1.26 (0.23-6.75)

c-erb-B2

15% vs. 23.1%

N.S.

0.41 (0.04-3.79)

Ki67

33.3% vs. 63%

p < 0.05

0.29 (0.08-0.98)

Delay Diag- treat (>30 days)

37.9% vs. 35.4%

N.S.

1.09 (0.33-3.59)

  1. ER: estrogen receptor, PR: progesterone receptor.